China launched the 55th and final satellite in the BeiDou Navigation Satellite System (BDS) at 9:43 a.m. (Beijing Time) on June 23. This is the third geostationary Earth orbit (GEO) satellite in the BDS-3 system.
Preliminary data from a clinical trial has shown that the vaccine developed by Chinese institutes induced high-titer antibodies in all those who had been inoculated. The result has been demonstrated though two different protocols and dosages.
China launched the last satellite of the BeiDou Navigation Satellite System (BDS) on June 23, marking the completion of the deployment of its own global navigation system.
On June 17, the National Center for Protein Science Shanghai made expression plasmids of all 29 proteins encoded by SARS-CoV-2 available to scientists around the world through a Protein Bank Program (PBP), according to the Shanghai Advanced Research Institute of the Chinese Academy of Sciences.
The Phase I/II clinical trials of the world's first inactivated COVID-19 vaccine, developed by Wuhan Institute of Biological Products under the China National Biotec Group (CNBG) affiliated to the China National Pharmaceutical Group (Sinopharm), produced antibodies in every participant, it was announced on Tuesday.
Approximately a decade ago, a photograph taken in front of two temporary rented offices at the Zhangjiang High-tech Park shows the legendary growth of iRay Technology Co Ltd, rising from a little-known start-up to a leading medical equipment supplier which has successfully broken the market monopoly on flat panel detector production.
The year 2020 marks the ASEAN-China Year of Digital Economy Cooperation. To further strengthen international cooperation and explore the potential of economic cooperation between ASEAN countries and China under the conditions of normalized COVID-19 prevention and control, the ASEAN-China Media & Think-Tank Online Forum was held on June 9 with the theme of “New Growth Points of ASEAN-China Digital Economy Cooperation.”
President Xi Jinping presided over a symposium on June 2 attended by experts and scholars. After this important meeting, some of the experts in medicine, public governance and law discussed how China's multi-dimensional response to the epidemic has achieved initial victory.
The Five-hundred-meter Aperture Spherical radio Telescope (FAST), the world's largest single-dish radio telescope located in China's Guizhou province, has detected a new fast radio burst (FRB), a radio pulse usually lasting only a few milliseconds, according to a report by the Science and Technology Daily.
Experts believe that the once COVID-19 epicenter of Wuhan has become a secure city, as Wuhan health authorities have tested nearly 10 million residents without discovering any new confirmed cases
The second meeting of the China Vaccine Industry Technological Innovation Strategic Alliance (CVITISA) was held in Beijing on May 18, brought together 27 institutions and companies engaged in vaccine research and development, production, supervision, and application. The aim of the meeting was to speed up the development of COVID-19 vaccines and strengthen technological innovation and cooperation in the vaccine field.
Brazilian researchers have discovered one of the causes of severe COVID-19 in diabetic patients. Laboratory experiments showed that the higher level of blood sugar in these patients is captured by monocytes, a type of defense cell, and serves as a source of additional energy for the coronavirus to replicate more than in a healthy organism. In response to the increased viral load, the monocytes release large amounts of pro-inflammatory cytokines with several effects including lung cell death.
According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category. The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.